Tuesday, April 3, 2018

European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab

PARIS, April 3 (Reuters) - The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)